Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03216291 · ClinicalTrials.gov registry record · NA
Home Versus Office Biofeedback Therapy for Fecal Incontinence
A NA study, sponsored by Augusta University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT03216291 is a NA study that has completed, run by Augusta University. The registered enrollment target is 33 participants.
The verdict
NCT03216291, a NA study, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Biofeedback therapy is a labor-intensive, multi-disciplinary, team approach for the management of patients with Fecal Incontinence. It is not easily available to the vast majority of patients in the community with this problem. It is therefore imperative that a more pragmatic therapeutic approach that can be administered easily in the community ought to be developed. However, whether a treatment program that is based on home-training can be just as useful as office-based training has not been evaluated. The purpose of this study is to assess whether having patients train their pelvic floor muscles at home is as effective as in-office biofeedback training.
Interventions
- BEHAVIORAL biofeedback therapy
- DEVICE Home Biofeedback therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2015-10 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03216291
The ClinicalTrials.gov registry entry for NCT03216291 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which biofeedback therapy is the first listed.
NCT03216291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03216291 about?
NCT03216291 is a clinical study titled "Home Versus Office Biofeedback Therapy for Fecal Incontinence". Biofeedback therapy is a labor-intensive, multi-disciplinary, team approach for the management of patients with Fecal Incontinence. It is not easily available to the vast majority of patients in the community with this problem. It is therefore imperative that a more pragmatic therapeutic approach th...
What is the current status of trial NCT03216291?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2015-10. Estimated completion is 2019-09-30.
What interventions are being tested in trial NCT03216291?
The interventions under investigation include: biofeedback therapy (BEHAVIORAL), Home Biofeedback therapy (DEVICE).
Who is sponsoring clinical trial NCT03216291?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.